Bone Marrow Failure Disorders
9 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Bone Marrow Failure Disorders| Treatment and condition | Where it stands | Trials |
|---|
| GVHD prophylaxis regimen + RIC regimen for bone marrow failure disorders | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Isatuximab for anemia, aplastic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for congenital bone marrow failure syndromes | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 2 Established Dose from prior study, NCT03810196 for congenital bone marrow failure syndromes | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for congenital bone marrow failure syndromes | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Rivogenlecleucel + rimiducid for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Romiplostim for anemia, aplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| thrombopoietin receptor agonist (TPO-RA) + Cyclosporine + ROMIPLOSTIM for anemia, aplastic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|